Abstract
The Benefit of Added Ranolazine to the Association of Angiotensin Receptor Blockers and Mineralocorticoid Receptor Antagonists Therapy for Ventricular Extrasystoles Treatment without the Use of Anti-Arrhythmic Drugs
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have